AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2015
Mar 23, 2015
29821_dirs_2015-03-23_e5e9ca21-2845-4fee-a2db-555b932e4437.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2015-03-19
Reporting Person: Phalen Michael P. (EVP & President, MedSurg)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-03-19 | Common Stock | S | 11085.0000 | $17.7685 | Disposed | 87981.0000 | Direct |
| 2015-03-20 | Common Stock | M | 35000.0000 | $12.5200 | Acquired | 122981.0000 | Direct |
| 2015-03-20 | Common Stock | S | 35000.0000 | $18.0000 | Disposed | 87981.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-03-20 | Stock Option (Right to Buy) | $12.5200 | M | 35000.0000 | Disposed | 2018-02-12 | Common Stock (35000.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2433.0000 | Indirect |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.7501 to $17.79, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
F4: Balance reflects the most current data available with regard to share holdings through the Boston Scientific Common Stock Fund under the Company's 401(k) Retirement Savings Plan.
F5: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 12, 2009, the first anniversary of the date of grant.
F6: The Form 3 filed by the reporting person on February 17, 2010 incorrectly reported the expiration date to be December 12, 2018. The expiration date reported on this Form 4 reflects the correct expiration date, which is February 12, 2018.